Breathe-Easy: Hayfever Care for Patients With Seasonal Allergic Rhinitis

Evaluation of Breathe-Easy Hayfever Care for Managing Symptoms in Patients With Seasonal Allergic Rhinitis

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06765239

Enrollment

Registered

2025-01-09

Start date

2024-04-24

Completion date

2024-06-15

Last updated

2025-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Rhinitis, Allergy Pollen, Hayfever

Keywords

Breathe-Easy, Hayfever Care

Brief summary

This waitlist-controlled trial aims to evaluate the therapeutic effectiveness of Hayfever Care by assessing disease-specific symptoms over a 4-week period. Additionally, the study examines the tolerability and safety of the solution.

Interventions

DIETARY_SUPPLEMENTHayfever Care

Powdered natural food supplement provided as a decoction, to be taken twice daily. Personalized Diet and Nutrition Guidance along with Lifestyle Advice

OTHERWait-list Control

Personalized Diet and Lifestyle Advice

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Mild to moderate symptoms during the hayfever season * Generally healthy individuals without chronic illnesses * Willingness to comply with study requirements, including completing symptom diaries.

Exclusion criteria

* History of anaphylaxis or severe hayfever symptoms requiring emergency treatment. * Pregnant or breastfeeding * History of substance abuse or excessive alcohol consumption. * Use of systemic corticosteroids, immunotherapy

Design outcomes

Primary

Measure	Time frame
Well-being Numerical Rating Scales	Change from Baseline to 4 weeks after baseline

Secondary

Measure	Time frame
Change of Symptom Itching Eyes	Change in symptom scores from baseline to 4 weeks.
Change of Symptom Burning Eyes	Change in symptom scores from baseline to 4 weeks.
Change of Symptom Respiratory Complaints	Change in symptom scores from baseline to 4 weeks.
Change of Symptom Dry Eyes	Change in symptom scores from baseline to 4 weeks.
Change of Symptom Rhinitis	Change in symptom scores from baseline to 4 weeks.
Change of Symptom Fatigue	Change in symptom scores from baseline to 4 weeks.
Change of Symptom Headache	Change in symptom scores from baseline to 4 weeks.
Change of Symptom Sneezing	Change in symptom scores from baseline to 4 weeks.

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026